Literature DB >> 22623069

Dietary supplement use is not associated with recurrence of colorectal adenomas: a prospective cohort study.

Renate C Heine-Bröring1, Renate M Winkels, Akke Botma, Peter J Wahab, Adriaan C I T L Tan, Fokko M Nagengast, Ben J M Witteman, Ellen Kampman.   

Abstract

Diet and lifestyle influence colorectal adenoma recurrence. The role of dietary supplement use in colorectal adenoma recurrence remains controversial. In this prospective cohort study, we examined the association between dietary supplement use, total colorectal adenoma recurrence and advanced adenoma recurrence. Colorectal adenoma cases (n = 565) from a former case-control study, recruited between 1995 and 2002, were prospectively followed until 2008. Adenomas with a diameter of ≥1 cm and/or (tubulo)villous histology and/or with high grade dysplasia and/or ≥3 adenomas detected at the same colonic examination were considered advanced adenomas. Hazard ratios (HRs) and 95% confidence intervals (CIs) for dietary supplement users (use of any supplement during the past year) compared to nonusers and colorectal adenoma recurrence were calculated using stratified Cox proportional hazard models for counting processes and were adjusted for age, sex, educational level and number of colonoscopies during follow-up. Robust sandwich covariance estimation was used to adjust for the within subject correlation. A number of 165 out of 565 adenoma patients had at least one colorectal adenoma recurrence during a median person-time of 5.4 years and of these, 37 patients had at least one advanced adenoma. One-third of the total study population (n = 203) used a dietary supplement. Compared to no use, dietary supplement use was neither statistically significantly associated with total colorectal adenoma recurrence (HR = 1.03; 95% CI 0.79-1.34) nor with recurrent advanced adenomas (HR = 1.59; 95% CI 0.88-2.87). This prospective cohort study did not suggest an association between dietary supplement use and colorectal adenoma recurrence.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22623069     DOI: 10.1002/ijc.27647

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2020-02-07       Impact factor: 22.682

2.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastrointest Endosc       Date:  2020-02-07       Impact factor: 9.427

3.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2020-03       Impact factor: 12.045

4.  Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers.

Authors:  Elahe Ramezanzade Tabriz; Monir Ramezani; Abbas Heydari; Seyed Amir Aledavood
Journal:  Asia Pac J Oncol Nurs       Date:  2021-10-04

5.  Vitamin D intake as well as circulating 25-hydroxyvitamin D level and risk for the incidence and recurrence of colorectal cancer precursors: A meta-analysis.

Authors:  Li-Liangzi Guo; Si-Si Chen; Li-Xian Zhong; Kai-Yin He; Yu-Ting Li; Wei-Wei Chen; Qiu-Ting Zeng; Shao-Hui Tang
Journal:  Front Med (Lausanne)       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.